To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TMEM104TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
125 supporting clones for gene TMEM104 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL701764 human skeletal muscle .a -10 to 551 1 to 562       562/562
(100 %)
2 diff
(99.7 %id)
BP284552 bone marrow .a -9 to 572 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
TI_1540413494   .a -9 to 265 278 to 5       274/299
(91 %)
6 diff
(98.0 %id)
DA430072 colon .a 1 to 544 10 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
TI_1540413400   .a 1 to 265 271 to 1       268/295
(90 %)
6 diff
(98.0 %id)
TI_1540413588   .a 4 to 265 263 to 2       262/294
(89 %)
1 diff
(99.7 %id)
BG327114 Kidney, renal cell adenocarcinoma .a 13 to 533 1 to 522       522/522
(100 %)
6 diff
(98.9 %id)
BC011552 Kidney, renal cell adenocarcinoma .a 14 to 3418 1 to 3405 V58M tiling clone, AAA   3405/3405
(100 %)
3 diff
(100.0 %id)
BC037278 testis .a 22 to 3418 1 to 3397 V58M available from MGC, AAA   3397/3397
(100 %)
10 diff
(99.8 %id)
BG721253 testis .a 22 to 611 1 to 594       594/595
(99 %)
19 diff
(96.9 %id)
BE243075 leukopheresis .a 25 to 250 1 to 226       226/226
(100 %)
2 diff
(99.2 %id)
DN999913   .a 26 to 662 7 to 642       636/650
(97 %)
8 diff
(98.8 %id)
CD243967 testis .a 34 to 780 1 to 747       747/877
(85 %)
9 diff
(99.0 %id)
AK291159   .a 69 to 1821 91 to 1843 V58M F270S     1843/1843
(100 %)
4 diff
(99.8 %id)
BM553264 brain, medulla .a 69 to 708 94 to 740   tiling clone,   740/1487
(49 %)
18 diff
(98.8 %id)
NM_017728.3   .a 69 to 4720 96 to 4747 exact RefSeq, AAA   4747/4747
(100 %)
0 diff
(100 %id)
DA740041   .a 69 to 538 91 to 564   capped   563/563
(100 %)
10 diff
(98.3 %id)
DN999695   .a 69 to 561 102 to 594       594/594
(100 %)
5 diff
(99.2 %id)
BQ309151 breast .a 134 to 518 10 to 392       383/395
(96 %)
8 diff
(98.0 %id)
BF530287 anaplastic oligodendroglioma with 1p/19qloss, brain .a 394 to 923 11 to 541       531/541
(98 %)
6 diff
(98.9 %id)
BI006749 kidney_tumor .a 628 to 1134 523 to 17       507/529
(95 %)
4 diff
(99.3 %id)
CD672352 eye, Iris .a 797 to 1317 1 to 521       521/521
(100 %)
0 diff
(100 %id)
AL137521 testis .a 862 to 4691 1 to 3830   tiling clone, available from DKFZ, AAA   3830/3830
(100 %)
6 diff
(99.9 %id)
BX452323 T cells (Jurkat cell line) .a 1467 to 2336 1 to 873       873/873
(100 %)
18 diff
(98.0 %id)
BG422393 Kidney, renal cell adenocarcinoma .a 1566 to 2321 1 to 743       743/743
(100 %)
16 diff
(97.9 %id)
BQ881559 sympathetic trunk .a 1631 to 2368 1 to 745       745/893
(83 %)
21 diff
(97.7 %id)
BQ878451 melanotic melanoma, cell line, skin .a 1799 to 2540 1 to 746       746/904
(82 %)
7 diff
(99.3 %id)
BQ682253 melanotic melanoma, cell line, skin .a 1799 to 2567 1 to 781       781/943
(82 %)
16 diff
(98.4 %id)
BU839311 melanotic melanoma, cell line, skin .a 1799 to 2588 1 to 794       794/956
(83 %)
20 diff
(98.0 %id)
BQ678159 melanotic melanoma, cell line, skin .a 1799 to 2597 1 to 798       798/943
(84 %)
22 diff
(97.7 %id)
BM545008 ovary (pool of 3) .a 1820 to 2625 18 to 823       806/1154
(69 %)
40 diff
(96.6 %id)
BI827197 brain, medulla .a 1823 to 2537 1 to 719       719/764
(94 %)
10 diff
(98.7 %id)
TI_57174882   .a 1823 to 2537 35 to 753       719/798
(90 %)
10 diff
(98.8 %id)
BG110472 Bone, osteosarcoma, cell line .a 1859 to 2550 1 to 689       689/690
(99 %)
8 diff
(98.9 %id)
CN358646 embryonic stem cells, cell lines H1, H7, andH9 .a 1913 to 2559 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
CB215304 normal endometrium, late proliferativephase, cycle day 13, uterus .a 2090 to 2623 1 to 534       534/534
(100 %)
0 diff
(100 %id)
DA872096 Prostate .a 2257 to 2822 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CF141795 CNCAP(3)T-225 cell line, Prostate .a 2536 to 2882 15 to 361       347/361
(96 %)
6 diff
(98.4 %id)
TI_154172589   .a 2536 to 2885 88 to 438       351/367
(95 %)
7 diff
(98.1 %id)
BF363377 nervous_normal .a 2545 to 2881 1 to 336       336/342
(98 %)
5 diff
(98.6 %id)
BF305969 muscle, rhabdomyosarcoma .a 2552 to 3227 1 to 678       678/678
(100 %)
14 diff
(98.0 %id)
BF307989 muscle, rhabdomyosarcoma .a 2552 to 3174 1 to 643       643/1028
(62 %)
10 diff
(99.1 %id)
DA300411 hippocampus .a 2596 to 3147 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
TI_154054542   .a 2604 to 3418 891 to 84   AAA   808/967
(83 %)
14 diff
(98.6 %id)
BQ683834 melanotic melanoma, cell line, skin .a 2628 to 2713 835 to 923       891/930
(95 %)
45 diff
(95.2 %id)
BE879874 large cell carcinoma, undifferentiated, lung .a 2687 to 3190 1 to 504       504/504
(100 %)
2 diff
(99.7 %id)
BF981854 duodenal adenocarcinoma, cell line, small intestine .a 2705 to 3501 1 to 787       787/911
(86 %)
39 diff
(95.8 %id)
CA418392 Chondrosarcoma Grade II, Left Pelvis .a 2724 to 3418 712 to 19   AAA   694/694
(100 %)
3 diff
(99.6 %id)
CD368230 Alveolar Macrophage, lung .a 2837 to 3418 601 to 19   AAA   583/583
(100 %)
3 diff
(99.5 %id)
DA344387 substantia nigra .a 2909 to 3263 2 to 356   capped   355/355
(100 %)
0 diff
(100 %id)
AI814493 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2909 to 3420 512 to 1       512/512
(100 %)
1 diff
(99.9 %id)
EC440091 Prostate .a 2920 to 2999 81 to 1       81/93
(87 %)
1 diff
(99.0 %id)
EC454250 Prostate .a 2920 to 2996 77 to 1       77/89
(86 %)
0 diff
(100 %id)
AW138270   .a 2925 to 3413 506 to 18   AAA   489/489
(100 %)
4 diff
(99.2 %id)
BX119715 anaplastic oligodendroglioma, brain .a 2957 to 3411 1 to 455       455/455
(100 %)
0 diff
(100 %id)
CA424137 cell lines, Chondrosarcoma .a 2963 to 3418 469 to 14   AAA   456/456
(100 %)
7 diff
(98.5 %id)
AI521116 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3001 to 3413 428 to 16   AAA   413/413
(100 %)
4 diff
(99.1 %id)
BQ300218 bladder_tumor .a 3062 to 3323 265 to 5       261/265
(98 %)
0 diff
(100 %id)
BM675440 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3160 to 3418 277 to 19   AAA   259/260
(99 %)
5 diff
(98.1 %id)
AA927043 pooled .a 3269 to 3391 123 to 1       123/123
(100 %)
0 diff
(100 %id)
DA568922 whole embryo, mainly head .a 3295 to 4095 2 to 798   tiling clone, capped   797/799
(99 %)
12 diff
(98.5 %id)
CD721873 eye, lacrimal gland .a 3419 to 4056 1 to 638       638/638
(100 %)
0 diff
(100 %id)
T84965 liver and spleen .a 3430 to 3763 1 to 333       333/491
(67 %)
10 diff
(98.0 %id)
BM698974 eye, fetal eyes .a 3431 to 4009 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BE906597 epithelioid carcinoma, Pancreas .a 3433 to 4047 1 to 640       640/640
(100 %)
58 diff
(91.0 %id)
CR984911 T-Lymphocytes .a 3481 to 4265 1 to 785       785/785
(100 %)
3 diff
(99.7 %id)
CN358645 embryonic stem cells, cell lines H1, H7, andH9 .a 3664 to 4168 1 to 504       504/504
(100 %)
6 diff
(98.9 %id)
BU178462 melanotic melanoma, skin .a 3770 to 4451 1 to 686       686/904
(75 %)
18 diff
(98.1 %id)
AA479232 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3776 to 4126 1 to 351       351/351
(100 %)
3 diff
(99.2 %id)
CD556506 brain, Pituitary .a 3777 to 4282 25 to 530       506/1004
(50 %)
6 diff
(99.5 %id)
CN358644 embryonic stem cells, cell lines H1, H7, andH9 .a 3895 to 4365 20 to 490       471/490
(96 %)
6 diff
(98.8 %id)
CA308316 Alveolar Macrophage, lung .a 4008 to 4689 700 to 19   AAA   682/682
(100 %)
1 diff
(99.9 %id)
CN479614 Chondrosarcoma, Left Pubic Bone .a 4009 to 4720 728 to 17   tiling clone, AAA   712/712
(100 %)
1 diff
(99.9 %id)
BU754169 placenta .a 4022 to 4689 686 to 19   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BU737405 eye, fetal eyes .a 4052 to 4691 656 to 17   AAA   640/640
(100 %)
1 diff
(99.9 %id)
BM998261 lung, Metastatic Chondrosarcoma .a 4054 to 4691 656 to 19   AAA   638/638
(100 %)
1 diff
(99.9 %id)
AW071914 anaplastic oligodendroglioma, brain .a 4084 to 4691 608 to 1       608/608
(100 %)
0 diff
(100 %id)
DB355497 whole embryo, mainly head .a 4140 to 4691 551 to 1       551/551
(100 %)
6 diff
(99.0 %id)
AI694507 carcinoid, lung .a 4194 to 4691 506 to 11   AAA   496/496
(100 %)
2 diff
(99.6 %id)
AW173104 pooled .a 4194 to 4690 502 to 7       496/502
(98 %)
0 diff
(100 %id)
BP306827   .a 4209 to 4689 1 to 481   AAA   481/481
(100 %)
0 diff
(100 %id)
BE045696 carcinoid, lung .a 4229 to 4689 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AI741268 pooled .a 4244 to 4690 453 to 7       447/453
(98 %)
0 diff
(100 %id)
AI942447 anaplastic oligodendroglioma, brain .a 4247 to 4707 464 to 1       464/464
(100 %)
4 diff
(99.2 %id)
BM688455 eye, human retina .a 4249 to 4692 2 to 445       444/445
(99 %)
5 diff
(98.9 %id)
AI017060 Kidney .a 4263 to 4691 439 to 11   AAA   429/429
(100 %)
0 diff
(100 %id)
AW006209 anaplastic oligodendroglioma, brain .a 4282 to 4690 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AI887557 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4292 to 4691 419 to 20   AAA   400/400
(100 %)
1 diff
(99.8 %id)
BG056240 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 4292 to 4689 415 to 18   AAA   398/398
(100 %)
1 diff
(99.8 %id)
AW510722 pooled .a 4295 to 4595 301 to 1       301/301
(100 %)
1 diff
(99.7 %id)
AW511302 pooled .a 4295 to 4692 405 to 8       398/405
(98 %)
0 diff
(100 %id)
AI697698 carcinoid, lung .a 4300 to 4689 404 to 16   AAA   389/389
(100 %)
5 diff
(98.8 %id)
AA479076.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4324 to 4689 388 to 23   AAA also hits gene C22orf13 366/366
(100 %)
0 diff
(100 %id)
T91215 liver and spleen .a 4334 to 4692 361 to 4       358/366
(97 %)
0 diff
(100 %id)
AA933955 pooled .a 4369 to 4692 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AA954774 pooled .a 4384 to 4692 316 to 8       309/316
(97 %)
0 diff
(100 %id)
BG120205 adenocarcinoma, cell line, Liver .a 4479 to 4689 1 to 211   AAA   211/211
(100 %)
0 diff
(100 %id)
BQ773361 Chondrosarcoma Cell line .a 4483 to 4691 227 to 19   AAA   209/209
(100 %)
1 diff
(99.6 %id)
BF512562   .a 4512 to 4658 16 to 162     Submitted on the opposite strand 147/171
(85 %)
1 diff
(99.5 %id)
BM691147 eye, RPE and Choroid .a 4537 to 4693 7 to 163       157/194
(80 %)
4 diff
(98.0 %id)
AK074029 Spleen .b 1 to 4676 1 to 4676 exact tiling clone, available from FLJ,   4676/4676
(100 %)
1 diff
(100.0 %id)
AK296621 colon .c -10 to 1770 1 to 1781 exact tiling clone,   1781/1781
(100 %)
1 diff
(100.0 %id)
DC344962 colon .c -10 to 559 1 to 570       570/570
(100 %)
0 diff
(100 %id)
AK000262 colon mucosa .d -9 to 1729 1 to 1739 V58M tiling clone, available from FLJ, AAA   1739/1739
(100 %)
4 diff
(99.8 %id)
BU556581 ovary, teratocarcinoma, cell line .e 1 to 860 4 to 865 F240X A243X     865/915
(94 %)
5 diff
(99.5 %id)
BC037584 Uterus, leiomyosarcoma .e 1 to 1145 1 to 1145 exact tiling clone, available from MGC, AAA   1145/1235
(92 %)
1 diff
(100.0 %id)
AL557191 T cells (Jurkat cell line), T cells from T cell leukemia .e 2 to 1009 1 to 1005 L90S M91W D92T M93C Y94T ...     1005/1005
(100 %)
36 diff
(96.5 %id)
BX445746 T cells (Jurkat cell line) .e 2 to 1053 37 to 1083 M4L I5L I10L I12L H14P ...     1047/1117
(93 %)
6 diff
(99.5 %id)
BM468410 leiomyosarcoma, uterus .e 2 to 956 51 to 1018 Q16L A243G available from MGC,   968/1131
(85 %)
43 diff
(96.2 %id)
AI905330 breast .e 54 to 244 30 to 221       192/231
(83 %)
5 diff
(97.9 %id)
BU431145 lymph .e 150 to 619 8 to 477       470/477
(98 %)
6 diff
(98.8 %id)
TI_154152989   .e 150 to 723 80 to 653       574/581
(98 %)
11 diff
(98.2 %id)
BQ277994 ovary, teratocarcinoma, cell line .e 544 to 1336 28 to 827   tiling clone,   800/1092
(73 %)
11 diff
(99.0 %id)
EC479660 Prostate .e 617 to 718 97 to 1       97/97
(100 %)
4 diff
(95.9 %id)
EC509059 Prostate .e 617 to 718 102 to 1       102/102
(100 %)
0 diff
(100 %id)
BG394372 eye, retinoblastoma .e 1152 to 1731 1 to 578       578/937
(61 %)
8 diff
(99.2 %id)
BE256763 eye, retinoblastoma .e 1172 to 1897 1 to 719   tiling clone,   719/739
(97 %)
12 diff
(98.4 %id)
BE251420 eye, retinoblastoma .e 1173 to 1746 1 to 573   tiling clone,   573/573
(100 %)
1 diff
(99.9 %id)
H03848 placenta .f 1 to 177 1 to 177   tiling clone,   177/212
(83 %)
2 diff
(99.1 %id)
H03849 placenta .f 190 to 598 413 to 1   tiling clone,   413/429
(96 %)
12 diff
(97.3 %id)
CB111554 Liver .g -9 to 524 1 to 534 exact tiling clone,   534/534
(100 %)
0 diff
(100 %id)
BM194300 leukopheresis .h 1 to 488 1 to 487 K124N S125H tiling clone,   487/487
(100 %)
3 diff
(99.4 %id)
DA790208 brain .i 1 to 379 2 to 380 G2R tiling clone, capped   379/379
(100 %)
2 diff
(99.5 %id)
AI720011 colon .i 181 to 630 450 to 1   tiling clone,   450/450
(100 %)
1 diff
(99.8 %id)
BX104156 colon .j-u 1 to 444 10 to 453 S39X W41X tiling clone,   444/455
(97 %)
2 diff
(99.6 %id)
BQ379985 uterus_tumor Gene TMEM104, variant not shown         This clone was ignored    
AV698062 hepatocellular carcinoma Gene TMEM104, variant not shown         Suspected internal deletion, this clone was ignored    
BG327845 Kidney, renal cell adenocarcinoma Gene TMEM104, variant not shown         Suspected internal deletion, this clone was ignored    
BP348972 brain Gene TMEM104, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI